Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
UBS
Chubb
Argus Health
Boehringer Ingelheim
Johnson and Johnson
QuintilesIMS
Cerilliant
Farmers Insurance
Chinese Patent Office

Generated: February 20, 2018

DrugPatentWatch Database Preview

ULTANE Drug Profile

« Back to Dashboard

When do Ultane patents expire, and what generic alternatives are available?

Ultane is a drug marketed by Abbvie and is included in one NDA. There is one patent protecting this drug.

This drug has forty-four patent family members in thirty-four countries.

The generic ingredient in ULTANE is sevoflurane. There are five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the sevoflurane profile page.
Summary for ULTANE
Drug patent expirations by year for ULTANE
Pharmacology for ULTANE
Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia

US Patents and Regulatory Information for ULTANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 AN RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ULTANE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie ULTANE sevoflurane LIQUID;INHALATION 020478-001 Jun 7, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for ULTANE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,083,514 Polymethylpentene container for an inhalation anesthetic ➤ Try a Free Trial
6,162,443 Container for an inhalation anesthetic ➤ Try a Free Trial
6,558,679 Container for an inhalation anesthetic ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for ULTANE

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
Medtronic
Argus Health
Moodys
Chubb
Colorcon
McKinsey
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot